• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cardinal Health celebrates medical product distribution center grand opening in Massachusetts

    10/29/24 11:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care
    Get the next $CAH alert in real time by email

    New facility in Boylston increases U.S. warehouse capacity and expands specialized handling capabilities

    DUBLIN, Ohio, Oct. 29, 2024 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today the grand opening of its new distribution center in Boylston, Massachusetts, supporting its U.S. Medical Products and Distribution business. The facility provides healthcare customers in Massachusetts, New Hampshire, Rhode Island, Maine, Vermont and Eastern Connecticut with modernized operations and expanded capacity, as well as specialized handling capabilities for products with strict storage requirements, available early 2025. At nearly 317,000 square feet, the new facility has replaced the Cardinal Health Bedford, Massachusetts, distribution center with double the warehouse space and triple the capacity for product storage locations.

    Cardinal Health Logo (PRNewsfoto/Cardinal Health)

    "Together with our dedicated operations and Cardinal Health leadership teams, we are happy to celebrate the grand opening of our new facility in Boylston and the positive impact our expanded footprint and unique product handling offerings will have on providers and their patients," said Mike Zatlukal, vice president, East Region Operations. "This larger building situated in an ideal location strengthens our supply chain resiliency, providing a more predictable, timely and stable experience for our New England customers and their growing needs."

    Increased distribution center capacity, enhanced operational efficiencies and specialized product handling capabilities – including refrigeration, proper storage for hazardous materials and industry expertise in product transportation regulations – offer customers in the New England market a single source of medical products for their patient care needs.

    "Today we celebrate the grand opening of Cardinal Health's state-of-the-art distribution center and significant investment in our region's healthcare infrastructure," said Meghan Kilcoyne, Massachusetts State Representative. "The new facility enhances the company's capacity to meet the increasing needs of healthcare providers across Massachusetts and New England. With a larger building and new location, Cardinal Health is poised to effectively support our dedicated healthcare professionals so they can focus on what truly matters—delivering exceptional patient care in our communities."

    Cardinal Health's investment in the new building demonstrates a continued commitment to growing its distribution footprint while driving operational excellence and supply chain resiliency across the care continuum. In 2023, Cardinal Health opened a 310,000-square foot replenishment center in Montgomery, New York, which strengthens on-hand inventory levels and the ability to rapidly restock its distribution network, which now includes the facility in Boylston. Earlier this year, Cardinal Health announced two new distribution centers – in Walton Hills, Ohio, opening in 2025 to support its U.S. Medical Products and Distribution business and in Greenville, South Carolina, now serving its at-Home Solutions business.

    About Cardinal Health

    Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With more than 50 years in business, operations in more than 30 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

    Contacts

    Media: Brittany Julian, [email protected]

    Investors: Matt Sims, [email protected] 

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-celebrates-medical-product-distribution-center-grand-opening-in-massachusetts-302288734.html

    SOURCE Cardinal Health

    Get the next $CAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • Where is Cardinal Health's new distribution center located?

      Cardinal Health's new distribution center is located in Boylston, Massachusetts.

    • What are the size and capacity benefits of the new distribution center compared to the old one?

      The new distribution center in Boylston is nearly 317,000 square feet, providing double the warehouse space and triple the product storage capacity compared to the previous facility.

    • What business does the new facility support, and which regions will benefit from it?

      The facility is designed to support the U.S. Medical Products and Distribution business, enhancing service to healthcare customers in several Northeastern states including Massachusetts, New Hampshire, and Rhode Island.

    • What operational improvements does Cardinal Health aim to achieve with the new facility?

      Cardinal Health aims to provide enhanced operational efficiencies and specialized product handling capabilities, including refrigeration and safe storage for hazardous materials, thereby improving supply chain resiliency.

    • What other facilities has Cardinal Health opened recently, and what does this indicate about their business strategy?

      In 2023, Cardinal Health also opened a 310,000-square-foot replenishment center in Montgomery, New York, and is planning new distribution centers in Walton Hills, Ohio, and Greenville, South Carolina, signifying ongoing expansion efforts.

    Recent Analyst Ratings for
    $CAH

    DatePrice TargetRatingAnalyst
    12/9/2025$243.00Overweight
    Barclays
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    12/13/2024$101.00 → $127.00Underweight → Equal Weight
    Wells Fargo
    12/4/2024$139.00Outperform
    Mizuho
    More analyst ratings

    $CAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cardinal Health Inc.

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    12/2/25 4:11:52 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    CEO, PSS Segment Weitzman Deborah covered exercise/tax liability with 551 shares, decreasing direct ownership by 1% to 52,877 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    12/2/25 4:11:35 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Chief Accounting Officer Scherer Mary C. covered exercise/tax liability with 61 shares, decreasing direct ownership by 2% to 3,495 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    12/2/25 4:11:15 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Financials

    Live finance-specific insights

    View All

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Nov. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on January 15, 2026 to shareholders of record at the close of business on January 2, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of

    11/4/25 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports First Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 22% to $64 billionGAAP1 operating earnings increased 18% to $668 million; GAAP diluted EPS increased 11% to $1.88Non-GAAP operating earnings increased 37% to $857 million, driven by segment profit growth across all five of the company's operating segments; non-GAAP diluted EPS increased 36% to $2.55Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $9.65 to $9.85 and fiscal year 2026 non-GAAP adjusted free cash flow outlook to $3.0 to $3.5 billionCardinal Health anticipates completing the acquisition of Solaris Health in early NovemberDUBLIN, Ohio, Oct. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today reported first quarter fiscal year 2026 revenues

    10/30/25 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Aug. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on October 15, 2025 to shareholders of record at the close of business on October 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator o

    8/15/25 4:40:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Nov. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on January 15, 2026 to shareholders of record at the close of business on January 2, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of

    11/4/25 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health completes acquisition of Solaris Health

    Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal Health's MSO platforms to ~3,000 providers in 32 states DUBLIN, Ohio, Nov. 3, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that it has completed its acquisition of Solaris Health, the country's leading urology MSO. Solaris Health brings more than 750 providers across more than 250 practice locations in 14 states and adds immediate scale to the Urology Alliance within Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance.

    11/3/25 8:30:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports First Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 22% to $64 billionGAAP1 operating earnings increased 18% to $668 million; GAAP diluted EPS increased 11% to $1.88Non-GAAP operating earnings increased 37% to $857 million, driven by segment profit growth across all five of the company's operating segments; non-GAAP diluted EPS increased 36% to $2.55Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $9.65 to $9.85 and fiscal year 2026 non-GAAP adjusted free cash flow outlook to $3.0 to $3.5 billionCardinal Health anticipates completing the acquisition of Solaris Health in early NovemberDUBLIN, Ohio, Oct. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today reported first quarter fiscal year 2026 revenues

    10/30/25 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    SEC Filings

    View All

    Cardinal Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CARDINAL HEALTH INC (0000721371) (Filer)

    11/6/25 4:13:37 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form 10-Q filed by Cardinal Health Inc.

    10-Q - CARDINAL HEALTH INC (0000721371) (Filer)

    10/30/25 8:48:43 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CARDINAL HEALTH INC (0000721371) (Filer)

    10/30/25 6:52:52 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Cardinal Health with a new price target

    Barclays initiated coverage of Cardinal Health with a rating of Overweight and set a new price target of $243.00

    12/9/25 8:43:24 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Cardinal Health from Equal Weight to Overweight and set a new price target of $179.00

    6/3/25 7:24:57 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health upgraded by Jefferies with a new price target

    Jefferies upgraded Cardinal Health from Hold to Buy and set a new price target of $150.00 from $140.00 previously

    2/5/25 7:09:45 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Leadership Updates

    Live Leadership Updates

    View All

    After Major Oncology Conference, All Eyes Turn to Industry Innovation

    USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

    6/12/25 9:00:00 AM ET
    $CAH
    $CTOR
    $CTXR
    Other Pharmaceuticals
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Carlisle Companies Announces Leadership Appointments

    Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

    5/16/25 4:05:00 PM ET
    $CAH
    $CSL
    $SUM
    Other Pharmaceuticals
    Health Care
    Specialty Chemicals
    Industrials

    Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

    DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e

    3/10/25 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    2/13/24 5:01:02 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    1/30/24 1:39:03 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    2/14/23 12:37:58 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care